Corisin-expressing non-human animal
Patent Information
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- MIE UNIVERSITY
- Filing Date
- 2025-12-17
- Publication Date
- 2026-06-25
Smart Images

Figure JPOXMLDOC01-APPB-T000001 
Figure JPOXMLDOC01-APPB-T000002 
Figure 00000031_0000
Abstract
Claims
1. A non-human animal containing cells with an expression cassette containing the coding sequence for corisin.
2. The non-human animal according to claim 1, wherein Corisin is a polypeptide comprising an amino acid sequence having 85% or more identity with the amino acid sequence shown in any of SEQ ID NOs: 1 to 11.
3. The non-human animal according to claim 1, wherein Corisin is a polypeptide comprising an amino acid sequence having 85% or more identity with the amino acid sequence shown in any of Sequence IDs 1 to 11, and having at least one selected from the group consisting of apoptosis-promoting activity, blood coagulation-promoting activity, epithelial-mesenchymal transition (EMT)-inducing activity, and cellular senescence-inducing activity.
4. The non-human animal according to claim 1, wherein the expression cassette further comprises a coding sequence for a human albumin signal peptide.
5. The non-human animal according to claim 1, wherein the non-human animal is a rodent.
6. The non-human animal according to claim 1, wherein the number of copies of the coding sequence for Corisin in the whole genome of the cell is 5 or more.
7. A model animal comprising a non-human animal as described in claim 1, for pathological analysis of organ fibrosis or inflammatory diseases and / or screening of therapeutic or prophylactic agents.
8. A fertilized egg or embryo that develops in a non-human animal as described in claim 1.
9. Cells comprising a Corisin expression cassette having an amino acid sequence that is 85% or more identical to the amino acid sequence shown in any of Sequence IDs 1 to 11, and having at least one selected from the group consisting of apoptosis-promoting activity, blood coagulation-promoting activity, epithelial-mesenchymal transition (EMT)-inducing activity, and cellular senescence-inducing activity.
10. A method for screening for prophylactic agents, ameliorative agents, and / or exacerbating agents of organ fibrosis or inflammatory diseases, using a model animal according to claim 7, a fertilized egg or embryo according to claim 8, or cells according to claim 9.